Epigenetics Market

Global Epigenetics Market Overview:

The latest report by IMARC Group, titled “Epigenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the epigenetics market size. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global epigenetics market size reached US$ 1.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2027, exhibiting a growth rate (CAGR) of 16.7% during 2022-2027.  Epigenetics refers to the study of the variations that occur in cellular and physiological traits without any change in the DNA sequence. It aids researchers in studying the impact of an individual’s behavior and environment, including age, diet, environmental pollutants, psychological stress and obesity, on their genes. Consequently, numerous academic and research institutes, pharmaceutical organizations, and biotechnology companies utilize epigenetics for research, diagnosis and treatment purposes.

Request Free Sample Report:  https://www.imarcgroup.com/epigenetics-market/requestsample

The global market is primarily driven by the increasing prevalence of chronic diseases across the globe. Additionally, continual technological advancements in the healthcare industry are providing an impetus to the market growth. For instance, the introduction of the Epi proLung test to detect the presence of lung cancer that is based on the combination of epigenomics’ proprietary DNA methylation biomarkers is creating a positive outlook for the market. Some of the other factors contributing to the market growth include the significant increase in investments by public and private agencies for upgrading the existing healthcare infrastructure and extensive research and development (R&D) activities conducted in biotechnology.

Global Epigenetics Market 2022-2027 Analysis and Segmentation

Competitive Landscape with Key Players:

  • Abcam plc
  • Active Motif Inc.
  • Agilent Technologies Inc
  • Diagenode Diagnostics (Hologic Inc)
  • Illumina Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Roche Holding AG
  • Thermo Fisher Scientific Inc
  • Zymo Research Corporation

Breakup by Product:

  • Reagents
  • Kits
    • Chip Sequencing Kit
    • Whole Genomic Amplification Kit
    • Bisulfite Conversion Kit
    • RNA Sequencing Kit
    • Others
  • Instruments
  • Enzymes
  • Services

By Technology:

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non-Coding RNA
  • MicroRNA Modification
  • Chromatin Structures

Breakup by Application:

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others

By Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East and Africa
  • Latin America

Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Leave a Reply

Your email address will not be published. Required fields are marked *